Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

被引：0
|
作者：
Maria F. Nunez
Armando Sardi
Carol Nieroda
William Jimenez
Michelle Sittig
Ryan MacDonald
Nail Aydin
Vladimir Milovanov
Vadim Gushchin
机构：
[1] Institute for Cancer Care at Mercy Medical Center,
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Peritoneal Carcinomatosis; Wound Complication; Port Site; Peritoneal Cancer Index; Complete Cytoreduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1658 / 1663
页数：5
相关论文
共 50 条
  • [41] Defining 'Complete Cytoreduction' After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
    Munoz-Zuluaga, C. A.
    King, M.
    Diaz-Sarmiento, V. S.
    Sittig, M.
    Nieroda, C.
    Gushchin, V.
    Sardi, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S84 - S85
  • [42] Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
    Carlos A. Munoz-Zuluaga
    Mary C. King
    Victor S. Diaz-Sarmiento
    Kimberley Studeman
    Michelle Sittig
    Ryan MacDonald
    Carol Nieroda
    Katherin Zambrano-Vera
    Vadim Gushchin
    Armando Sardi
    [J]. Annals of Surgical Oncology, 2020, 27 : 5026 - 5036
  • [43] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation
    Noiret, B.
    Piessen, G.
    Eveno, C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 5448 - 5449
  • [44] Obesity and Peritoneal Surface Disease Outcomes Following Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Votanopoulos, K. I.
    Swett, K.
    Swords, D. S.
    Shen, P.
    Stewart, J. H.
    Levine, E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S113 - S113
  • [45] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach
    Andrea Hayes-Jordan
    C. Lopez
    H. L. Green
    L. C. Xiao
    W. Huh
    C. E. Herzog
    [J]. Pediatric Surgery International, 2016, 32 : 71 - 73
  • [46] Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Konstantinos I. Votanopoulos
    Reese W. Randle
    Brandon Craven
    Katrina R. Swett
    Edward A. Levine
    Perry Shen
    John H. Stewart
    Majid Mirzazadeh
    [J]. Annals of Surgical Oncology, 2014, 21 : 868 - 874
  • [47] Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad
    Petursdottir, Astriour
    Gunnarsson, Orvar
    Valsdottir, Elsa B.
    [J]. LAEKNABLADID, 2020, 106 (7-8): : 344 - 348
  • [48] Obesity and peritoneal surface disease: Outcomes following cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
    Votanopoulos, Konstantinos I.
    Swett, Katrina R.
    Swords, Doug S.
    Shen, Perry
    Stewart, John
    Levine, Edward A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [49] Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Votanopoulos, Konstantinos I.
    Randle, Reese W.
    Craven, Brandon
    Swett, Katrina R.
    Levine, Edward A.
    Shen, Perry
    Stewart, John H.
    Mirzazadeh, Majid
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 868 - 874
  • [50] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation
    B. Noiret
    G. Piessen
    C. Eveno
    [J]. Annals of Surgical Oncology, 2021, 28 : 5448 - 5449
12345